Swiss National Bank X Biotech Inc. Transaction History

Swiss National Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$5.13 - $9.2 $240,084 - $430,559	-46,800 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.64 - $11.71 $32,832 - $44,498	3,800 Added 8.84%	46,800 $404,000
Q3 2021 Nov 08, 2021	BUY	$12.95 - $18.24 $14,245 - $20,064	1,100 Added 2.63%	43,000 $557,000
Q2 2021 Aug 06, 2021	BUY	$15.83 - $17.84 $134,555 - $151,640	8,500 Added 25.45%	41,900 $694,000
Q1 2021 May 07, 2021	BUY	$15.92 - $20.3 $19,104 - $24,360	1,200 Added 3.73%	33,400 $573,000
Q2 2020 Aug 05, 2020	BUY	$10.39 - $16.07 $334,558 - $517,454	32,200 New	32,200 $441,000
Q4 2017 Feb 07, 2018	SELL	$3.9 - $4.66 $122,850 - $146,790	-31,500 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$4.14 - $5.12 $130,409 - $161,280	31,500	31,500 $138,000

4.84M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $212M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.